Stanford University
Showing 20,701-20,800 of 36,179 Results
-
Rishi Mediratta
Clinical Associate Professor, Pediatrics
Current Research and Scholarly InterestsI have developed a new promising neonatal mortality prediction score at the University of Gondar Neonatal Intensive Care Unit (NICU) in Gondar, Ethiopia. The score predicts approximately 84% of neonatal deaths in the NICU using clinical variables. I have a dataset over 800 NICU admissions in Gondar. I am recruiting scholars who are interested in conducting clinical and epidemiological research to validate, refine, and implement the mortality score to reduce neonatal mortality in Ethiopia.
-
Sangeeta Mediratta
PWR Lecturer
BioSangeeta Mediratta teaches classes on rhetoric and writing, literature and film. Her PWR classes currently focus on maps, borders, networks, objects, and objectification. She loves learning about and helping her students develop their research interests and projects and takes great joy in fostering strong class communities centered around writing and research.
She completed her Ph.D. from University of California, San Diego in English Literature. Her dissertation :Bazaars, Cannibals, and Sepoys: Sensationalism and Transnational Cultures of Empire" studied at the ways texts, objects, and spectacles in the U.S. and Britain drew upon imperial stories and objects to critique contemporary social formations. She has also written on world cinema, popular culture, disability studies, as well as gender and race studies.
Her current research focuses on the materiality of writing and on how students use culture as a way to build campus communities. She is also interested in empathy as a mode of living, connecting, writing, and being. -
Natalia Medvedeva
Clinical Assistant Professor, Medicine - Infectious Diseases
BioDr Natalia Medvedeva specializes in the treatment of infectious diseases. She has a special interest in antimicrobial stewardship and medical education.
-
Lúcia Mees
MBA, expected graduation 2026
Course Asst-Graduate-Hourly, SeruBioElectrical and Computer Engineer & Entrepreneur with focal interest in Artificial Intelligence and IoT. Currently working in the development of next-gen smart cities in Brazil, the world's 2nd most advanced country in digital government.
My work focuses on innovation and digital transformation strategy, developing short, medium and long-term roadmaps for technology solutions propelling public administration over hundreds of cities in the country. Under my leadership at IPM, our SaaS platform has been awarded as the best solution for smart cities in Brazil, as one of the 2 most innovative software companies in Southern Brazil, and as the 5th best HR team in the country. -
Eric Meffre
Professor of Medicine (Immunology and Rheumatology)
BioDr. Meffre obtained his PhD in Immunology from the Université d’Aix-Marseille in France before he moved to the USA as a postdoc fellow in the laboratory of Dr. Michel Nussenzweig at The Rockefeller University in New York City. He became an assistant professor at Cornell University in 2003 before being recruited at Yale University as associate professor in 2009. He was tenured at Yale in 2014 before he joined the Department of Medicine/Division of Immunology and Rheumatology at Stanford University as a tenured full professor in 2022.
Dr. Meffre’s work focuses on the etiology of autoimmune syndromes and the roles played by B cells in these diseases. His group characterized the abnormal selection of developing autoreactive B cells in patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), type 1 diabetes (T1D), multiple sclerosis (MS) and Sjögren’s syndrome, resulting in large numbers of autoreactive naïve B cells accumulating in the patient’s blood. Hence, these autoreactive B cells may present self-antigens to T cells and initiate autoimmune diseases. These early B cell tolerance defects are likely primary to these autoimmune diseases and may result from genetic factors such as the 1858T PTPN22 allele that segregates with RA, SLE and T1D and correlate with an impaired removal of developing autoreactive B cells.
His research goals also consist in characterizing the molecules and pathways involved in the establishment of B cell tolerance and the removal of developing autoreactive B cells generated by random V(D)J recombination through the investigation of rare patients with primary immunodeficiency (PID) enrolled through an international network. Alteration of B cell receptor (BCR) or Toll-like receptor (TLR) signaling in PID patients results in a defective central B cell tolerance and a failure to counterselect developing autoreactive B cells in the bone marrow. In contrast, functional and suppressive regulatory T cells play a key role in preventing the accumulation of autoreactive clones in the mature naïve B cell compartment. The recent development of humanized mouse models recapitulating early B cell tolerance checkpoints and their defects in autoimmune settings allow further in-depth investigation of tolerance mechanisms and the development of novel approaches to restore defective central and peripheral B cell tolerance checkpoints and thwart autoimmunity. -
Jessica Lee Mega
Affiliate, Medicine - Med/Cardiovascular Medicine
BioJessica L. Mega, MD, MPH is a leader at the intersection of technology, life science, and health. She is a Cardiologist at Stanford and serves on the Advisory Board for Stanford's Center for Digital Health. She is a Co-Founder of Alphabet's Verily and former Chief Medical Officer of Google Life Sciences. She is on the Board of Directors at Boston Scientific and Danaher Corporation, as well as the Board of Advisors for Research!America and the Duke-Margolis Center for Health Policy. She is a Senior Advisor at SandboxAQ and the Chair of the Investment Committee of the American Heart Association’s GRFW Venture Fund.
As a faculty member at Harvard Medical School, a Senior Investigator with the TIMI Study Group, and a Cardiologist at Brigham and Women’s Hospital, Dr. Mega led large, international, randomized trials evaluating novel therapies and new medical technologies. She directed the TIMI Study Group’s Genomics Program, demonstrating and testing the role of CYP2C19 genetic variants on antiplatelet medications, a key pharmacogenetic finding. She has published manuscripts in the New England Journal of Medicine, Lancet, and JAMA. She served as an Advisor for the California Governor’s Precision Medicine Initiative.
Dr. Mega is a graduate of Stanford University, Yale University School of Medicine, and Harvard School of Public Health. She completed Internal Medicine Residency at Brigham and Women’s Hospital and Cardiovascular Fellowship at Massachusetts General Hospital. She is board certified in Internal Medicine and Cardiology. She has won the Laennec Society, Samuel A. Levine, and Douglas P. Zipes Awards, and she is a Fellow of the American Heart Association and the American College of Cardiology. -
Uchechukwu Megwalu, MD, MPH
Professor of Otolaryngology - Head & Neck Surgery (OHNS)
Current Research and Scholarly InterestsOutcomes Research
Health Disparities
Comparative Effectiveness Research
Health Literacy
Head and Neck Cancer Epidemiology
SEER database analysis -
Thulaj Dattatraya Meharwade
Postdoctoral Scholar, Cardiovascular Institute
BioDr. Thulaj Meharwade is a postdoctoral fellow at the Stanford Cardiovascular Institute with research interests in Inflammaging, disease modeling, cellular heterogeneity and drug discovery. Dr. Meharwade received his PhD in Biochemistry from the University of Montreal, after conducting thesis work on signalling and transcriptional mechanisms regulating cell fate heterogeneity and totipotent stem cells.
-
Rania Zuri
Undergraduate, Vice Provost for Undergraduate Education
BioRania Zuri is the founder and CEO of The LiTEArary Society, the world’s largest youth-led nonprofit organization working to end book deserts for disadvantaged preschool children. To date, The LiTEArary Society has donated more than $1 million worth of brand new books to over 91,000 disadvantaged preschool children in all 50 states. The LiTEArary Society has partnerships and has received funding from Scholastic, Inc., Barnes & Noble, L'Oréal, Hershey’s, Pilot Pens, and Starbucks.
For her work in early childhood literacy, she has been featured on Good Morning America, Forbes, NBC Nightly News with Lester Holt, The Today Show, The Kelly Clarkson Show (x2), CBS Evening News, NPR, Fox News, Teen Vogue, The Washington Post, NowThis, The Hill, People Magazine, and more.
She was named by Forbes as one of "Six Teens Making the World a Better Place” in 2022 and made the Forbes 30 under 30 list in 2024 as the youngest CEO on the entire list. In 2023, Rania received The Diana Award, one of the most prestigious international accolades a young person (ages 8 to 25) can receive for social or humanitarian work and was one of only 3 recipients out of the 189 global recipients to be introduced by Prince Harry. In 2023, Rania was honored at the White House by the First Lady of the United States as a "Girl Leading Change" in celebration of International Day of the Girl. Most recently, Rania was honored by L'Oréal Paris as a L’Oréal Woman of Worth, L'Oréal's signature philanthropic initiative which honors 10 female leaders each year.
Rania has given a TEDx Talk on book deserts with over 43,000 views on TED.com and Youtube and was the keynote speaker at the annual WV Head Start Conference. She has written op-eds for Teen Vogue and NBC News Online on education as well. She serves as an ambassador for many organizations and corporations, including the United Nations Association (as a UNA-USA Global Goals Ambassador for Sustainable Development Goal #4).
She is the youngest author of a US Senate Resolution in U.S. history and has written a children’s picture book series (sold in-store at select Barnes & Noble stores) where 100% of the profits go to the purchase of brand-new Scholastic books for preschool children in Head Start programs.
Rania is a Coca-Cola Scholar, a U.S. Presidential Scholar, a Cameron Impact Scholar, a Taco Bell Live Mas Scholar, winner of the Gloria Barron Prize for Young Heroes, and has received 3 US Congressional Commendations as well as the George H.W. Bush Point of Light Award. -
Apurva Mehta
Senior Scientist, SLAC National Accelerator Laboratory
BioI am a materials scientist with three decades of experience unraveling the molecular-scale processes that govern the functionality, aging, and failure of complex materials and devices. Over this time, advanced characterization methods have undergone a revolutionary transformation, driven by the emergence of brighter sources—from synchrotrons and X-ray free-electron lasers to MeV accelerator-based electron sources—paired with faster and larger-area detectors. While the depth and precision of measurements have vastly improved, the explosion of raw data now poses a significant challenge, making it increasingly difficult to extract meaningful insights them.
Recognizing this growing challenge, I have devoted the last decade to harnessing the power of emerging machine learning and artificial intelligence techniques to find breakthroughs. My focus has been on not only accelerating the extraction of knowledge from intricate, multi-dimensional, and often noisy measurements but also on making data collection smarter. By integrating these cutting-edge technologies, I aim to transform how we approach material science and deepen our understanding of material behavior and device performance. -
Arnav Mehta, MD, PhD
Adjunct Clinical Assistant Professor, Medicine - Oncology
BioDr. Mehta is a board-certified, fellowship-trained medical oncologist at the Stanford Medicine Cancer Center. He is also an adjunct clinical assistant professor in the gastrointestinal (GI) oncology group of the Department of Medicine, Division of Oncology at Stanford University School of Medicine.
Dr. Mehta specializes in gastrointestinal cancer, with a particular focus on pancreatic and gastric cancers. He also treats colorectal cancers. His treatment specialties include immunotherapy — helping a patient’s immune system fight cancer — and targeted therapies, which send cancer-fighting drugs to specific cancer cell molecules.
His research interests include understanding why GI cancers resist treatments and identifying new ways to treat these tumors. In particular, he is interested in GI tumor immunology, which focuses on directing a person’s immune system to help destroy cancer cells. He also has a special interest in tumor plasticity, which represents the ability of a tumor cell to evolve and develop resistance to therapies.
Dr. Mehta has earned research awards and grants from organizations including the American Association for Cancer Research (AACR), American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH), and the National Institutes of Health.
Dr. Mehta has published in many peer-reviewed journals, including Nature, Nature Genetics, Nature Immunology, Nature Medicine, Nature Cancer, Cancer Discovery and Immunity. He has written book chapters on subjects including esophageal and gastric cancer. He has also presented his research on topics including tumor immunology and pancreatic cancer at dozens of symposia and meetings around the country.
Dr. Mehta is a member of the AACR and ASCO. -
Krish Mehta
Affiliate, Graduate School of Business - Center for Entrepreneurial Studies
BioPassionate about cleantech / climate entrepreneurship. Previously, manager for Model 3 program at Tesla, and Engagement manager at McKinsey's Sustainability practice.
-
Niraj Mehta
MBA, expected graduation 2027
Current Research and Scholarly InterestsPlants provide some of the most important drugs in current clinical use. It can be challenging to chemically synthesize these drugs or sustainably source them from producer plants. These issues could be alleviated if their biosynthetic genes are engineered into heterologous organisms for large-scale production. I am interested in a) understanding how plants produce these valuable drugs and b) engineering the sustainable production of these drugs into other plants for large-scale production.
-
Jenny Y. Mei
Clinical Assistant Professor, Obstetrics & Gynecology - Maternal Fetal Medicine
Current Research and Scholarly InterestsPostpartum hypertension
Cardio-obstetrics
Quality improvement -
Yuchen Mei
Ph.D. Student in Electrical Engineering, admitted Autumn 2023
BioYuchen Mei is an EE Ph.D. student at Stanford University in Prof. Priyanka Raina's group. He received a B.S. degree in Electronic Information Science and Technology from Nanjing University (China) in 2021 and a M.S. degree in Electrical Engineering from Stanford in 2023. He is interested in digital VLSI design, domain-specific accelerators, and design automation.
-
Simona Meiler
Postdoctoral Scholar, Civil and Environmental Engineering
BioI am a weather and climate risk scientist, studying how hazard, exposure, and vulnerability interact to shape the risks and impacts of extreme weather events – both today and in a changing climate. My work combines modeling and systems thinking to explore a range of topics, including tropical cyclone risk, uncertainty and sensitivity analysis, human displacement, post-disaster recovery, and systemic risk. My approach is inherently interdisciplinary, with the goal of translating model insights into real-world applications that support climate-resilient decision-making.
I am currently a postdoctoral researcher at Stanford University, supported by an SNSF Postdoc.Mobility fellowship, working with Prof. Jack W. Baker. I completed my PhD at ETH Zurich in weather and climate risk modeling, with a focus on global tropical cyclone risk and uncertainty quantification, under the supervision of Prof. David N. Bresch. -
Caroline Meinhardt
Policy Research Manager, Institute for Human-Centered Artificial Intelligence (HAI)
BioCaroline Meinhardt is the policy research manager at the Stanford Institute for Human-Centered Artificial Intelligence (HAI), where she develops and oversees policy research initiatives. She is passionate about harnessing AI governance research to inform policies that ensure the safe and responsible development of AI around the world—with a focus on the implementation challenges of AI regulation, the governance of large-scale AI models, and global AI governance approaches. Prior to joining HAI, Caroline worked as a China-focused consultant and analyst, managing and delivering in-depth research and strategic advice regarding China’s development and regulation of emerging technologies including AI. She holds a Master's in International Policy from Stanford University and a Bachelor's in Chinese Studies from the University of Cambridge.
-
Doug Meisenheimer
Lab Manager - Micro-CT Facility, Stanford Doerr School of Sustainability - Dean's Office
Current Role at StanfordResearch Scientist and Lab Manager for the MicroCT (MCT) and Mineralogy & Petrology (M&P) shared labs in the Doerr School of Sustainability.
-
Kara Meister, MD, FAAP, FACS
Assistant Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Pediatrics
BioKara D. Meister, MD, FAAP, FACS is a pediatric otolaryngologist and head & neck surgeon. She received her medical degree from Medical University of South Carolina and completed her otolaryngology residency at University of Pittsburgh. She completed a NIH-funded fellowship in head and neck research at the University of Pittsburgh. Dr. Meister then went on to complete a pediatric otolaryngology fellowship at Lucile Packard Children’s Hospital Stanford.
She is currently an Assistant Professor in the Department Otolaryngology, Division of Pediatric Otolaryngology, at Stanford University. Dr. Meister’s research interests include thyroid cancer, head & neck masses, Graves' disease. She has a special interest in the influence of the environment and pollutants (such as microplastics) on health. She currently serves as the Co-Clinical Chief of Pediatric Otolaryngology. Dr. Meister completed additional training in innovation through the Stanford Biodesign Faculty Fellowship.
Her clinical interests include the treatment of patients with head and neck masses including thyroid nodules and cancer. She is Co-Director, Surgical, of the Children's Thyroid Center at Lucile Packard Children’s Hospital Stanford and is a participating surgeon in the Aerodigestive and Airway Reconstruction Center at Stanford Children’s Health. She is co-editor of the textbook "Pediatric Bronchoscopy for Clinicians" and enjoys advocacy work with the American Academy of Pediatrics Button Battery Taskforce.
Dr. Meister is a member of the American Thyroid Association (ATA) where she serves on the Diversity, Equity, and Inclusion committee and is a member of the ATA Guidelines Writing Group for Thyroid Disease & Pregnancy. She is a member of the pediatric committee of the American Head and Neck Society. She is an author and speaker on masses and tumors of the head and neck, thyroid disease, and thyroid cancer in children and adolescents. In collaboration with SHC, she offers novel treatment for thyroid problems in children and adolescents including radiofrequency ablation of thyroid nodules.
Dr. Meister lives in Woodside with her husband, 3 children, and Rooney the dog.
Clinical Expertise:
Children's Thyroid Center, Co-Director, Surgical
Thyroid nodules
Thyroid cancer - papillary, follicular, and medullary
Surgical management of hyperthyroidism and Grave's disease
MEN syndrome
Head and Neck masses
Congenital neck masses such as branchial cleft cyst, thyroglossal duct cyst
Pediatric Head and Neck cancer
Airway evaluation and reconstruction, voice and swallowing problems, and Aerodigestive
Fetal Airway and Exit Team -
Christian V. Mejia
Lecturer
BioChristian Mejia (he/they) believes that light has the ability to transport us to a moment in time and cradle us within a particular place. Light affects our mood, informs our emotional landscape, and enhances the everyday moments that make up our lives. The right light can tell a story that goes beyond words.
Christian’s approach to design seeks to create environments that ask people to lean into and learn something about our shared humanity. His design practice includes live performance, architectural lighting, and immersive entertainment. His work has been seen on stages and in built environments around the world. Some of his most cherished theatrical collaborations include the Geffen Playhouse (Los Angeles), Fountain Theatre (Los Angeles), Edinburgh Fringe Festival (Scotland), ACT (San Francisco), and New Conservatory Theatre Center (San Francisco). His architectural lighting design practice has included work with Universal Creative, Lincoln Center NYC, and global Soho House properties.
Christian received his BFA from New York University’s Tisch School of the Arts and his MFA from California Institute of the Arts. See a selection of his work at christianvmejia.com. -
Luis Mejia
Affiliate, Materials Science and Engineering
BioLuis has been a technology transfer professional at Stanford for over 30 years. He is a volunteer for Climate Donor, Inc. a non-profit that helps fund climate change and species extinction mitigation projects. Prior to joining Stanford he worked on solar energy systems and energy management at Honeywell and Pacific Gas & Electric. He has a degree in Energy Systems Engineering from Arizona State University, is a Fellow of the Disruptor Foundation and is a recipient of an award for Excellence in Technology Transfer from the Department of Energy, Federal Laboratory Consortium.
-
Javier Mejia
Lecturer
BioI am a Lecturer in the Department of Political Science at Stanford University. I am also a member of the Stanford Civics Initiative and an affiliated faculty of the Stanford Center for Latin American Studies and the Stanford Center for Poverty and Inequality. I have been a Lecturer and a Postdoctoral Associate in Economics at New York University Abu Dhabi and a Visiting Scholar at the University of Bordeaux. I received my Ph.D. in Economics from the University of Los Andes. My research centers on the intersection between social networks and economic history, extending to entrepreneurship and political economy topics.
My geographical areas of specialty are Latin America and the Middle East.
I regularly contribute to different news outlets. Currently, I am a Forbes Magazine op-ed columnist.
I am also the host of The Economic and Political History Podcast and The Civic Agora. -
Zariah Mekile
Affiliate, Psychiatry and Behavioral Sciences
BioZariah J. Mekile, MS, MAP, is a doctoral candidate at the PGSP-Stanford Psy.D. Consortium, where she is pursing her PsyD in Clinical Psychology. She completed a BA in psychology with a minor in cognitive science and Spanish at Elizabethtown College, and a Master of Applied Psychology at Rutgers University-Graduate School of Applied and Professional Psychology.
-
Bethlehem Mekonnen, MD
Clinical Assistant Professor, Ophthalmology
BioDr. Mekonnen is a board-certified, fellowship-trained ophthalmologist with the Byers Eye Institute at Stanford Health Care. She is also a clinical assistant professor of medicine in the Department of Ophthalmology.
Dr. Mekonnen diagnoses and treats a wide range of eye conditions, including cataracts, corneal and external eye diseases. She creates an individual, comprehensive care plan for each of her patients.
Dr. Mekonnen’s clinical research interests include exploring the most effective medical and surgical therapies for patients with corneal and external eye diseases. She has researched and published on outcomes of macular edema, described a novel surgical technique for severe ocular surface disease and described a possible new ophthalmic manifestation of a rare congenital disorder called Cobb syndrome.
Dr. Mekonnen has published work in the American Journal of Ophthalmology, Cornea: The Journal of Cornea and External Disease, and the Journal of Ophthalmic Inflammation and Infection. She has presented to her peers at the Association for Research in Vision and Ophthalmology, Women in Ophthalmology (WIO) Summer Symposium, and the Annual GlaxoSmithKline Women in Science Conference.
Dr. Mekonnen is a member of the American Academy of Ophthalmology. -
Mads Melbye
Visiting Professor, Pediatrics - Neonatology
BioMads Melbye, MD, DMSc, is visiting Professor in the Department of Pediatrics at Stanford University School of Medicine. He is also Director of the Danish Cancer Institute (DCI), Research Director at the Danish Cancer Society in Denmark, and Professor in Medical Epidemiology at the Norwegian University of Science and Technology. From 2016-2020 he was President and CEO at Statens Serum Institut, Copenhagen, Denmark. Previous positions at e.g. the National Cancer Institute, NIH, USA, before he became State Epidemiologist in Denmark, and later Head of Department of Epidemiology Research, and Division Director of Epidemiology and Disease Surveillance, Statens Serum Institut. Previous academic positions as Danish Research Council Professor, NORFA professor, and Foreign Adjunct Professor at Karolinska Institute in Sweden. He has written more than 700 publications (H-index: 115/141 (Web of Science/Google scholar) and is the Dane with most papers in high impact journals in general medicine (NEJM, Lancet, JAMA). He is among the worlds top 2% of scientists as listed in the AD Scientific Index 2023. He is knighted by Her Majesty Queen Margrethe II of Denmark, and has received e.g. the Novo Nordisk Prize, the large Erhoff Prize, and the Anders Jahre Prize (young researchers). He is e.g. chairman of the scientific committee at the Danish Health Insurance Fund, member of the scientific advisory board for Oslo University Hospital, member of the A.P. Møller and Chastine Mc-Kinney Møller Foundation (medicine), and board member of the Norwegian Cancer Registry. Has previously served as e.g. chairman of the Governing Council, WHO's International Agency for Research on Cancer in Lyon, France, chairman of the Nordic Medical Research Council’s coordinating body (NOS-M), vice-chairman of the Danish Medical Research Council, chairman of the Ministry of Science, Technology and Innovation's committee on Registry Research (KOR), chairman of the Scientific Council, IARC, Lyon, France, and member of the Novo Nordisk Prize Committee. Together with Professor Stephen Quake he founded Mirvie Inc. in 2018, a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health.
-
Marc L. Melcher
Stanford Department of Surgery Professor
Current Research and Scholarly InterestsMy goal is to extend the benefits of organ transplantation to greater numbers of patients while maintaining excellent outcomes. We developed the "paired-organ exchange" program at Stanford to increase the chances that patients with willing but incompatible living donors can still receive a living donor kidney. In addition, I am applying artificial intelligence algorithms to facilitate complex decision making in liver transplant.
-
Esmeralda Melgoza
Postdoctoral Scholar, Emergency Medicine
BioEsmeralda Melgoza, PhD, MPH, CHES is a postdoctoral researcher in the Department of Emergency Medicine at Stanford University's School of Medicine. Her research examines health inequities in the U.S. healthcare system, with a focus on emergency medical services provided in the prehospital setting and the emergency department. She centers her research on the experiences of underserved populations, including Latine/Hispanics, older adults, and people with limited English proficiency. She is trained in both quantitative and qualitative methods. Her research has been published in peer-reviewed journals, including Medical Care, Health Affairs Scholar, Prehospital Emergency Care, SSM-Qualitative Research in Health, and Prehospital and Disaster Medicine, among others. She is a current recipient of a grant from the CARESTAR Foundation.
Dr. Melgoza received her PhD in Community Health Sciences from the UCLA Fielding School of Public Health and a minor in Gerontology from the USC Leonard Davis School of Gerontology. Her dissertation research was funded by an R36 grant from the National Institute on Aging. Dr. Melgoza is a former Senior Research Analyst at the UCLA Latino Policy and Politics Institute and an alumna of the Yale Ciencia Academy at Yale University. She is bilingual in English and Spanish. In her spare time, she enjoys spending time with her family, traveling, mentoring, and hiking. -
Elizabeth Mellins
Member, Bio-X
Current Research and Scholarly InterestsMolecular mechanisms and intracellular pathways of MHC class II antigen processing and presentation, with a focus on B cells; mechanisms underlying HLA allele association with disease; disease mechanisms in systemic juvenile idiopathic arthritis, including an HLA-linked complication; monocytes as drivers or suppressors of auto-inflammation in systemic juvenile idiopathic arthritis and pediatric acute neuropsychiatric syndrome.
-
Michelle Mello
Professor of Law and of Health Policy
BioMichelle Mello is Professor of Law at Stanford Law School and Professor of Health Policy in the Department of Health Policy at Stanford University School of Medicine. She conducts empirical research into issues at the intersection of law, ethics, and health policy. She is the author of more than 250 articles on medical liability, public health law, the public health response to COVID-19, pharmaceuticals and vaccines, biomedical research ethics and governance, artificial intelligence, health information privacy, and other topics.
The recipient of a number of awards for her research, Dr. Mello was elected to the National Academy of Medicine at the age of 40. From 2000 to 2014, she was a professor at the Harvard School of Public Health, where she directed the School’s Program in Law and Public Health.
Dr. Mello teaches courses in torts and public health law. She holds a J.D. from the Yale Law School, a Ph.D. in Health Policy and Administration from the University of North Carolina at Chapel Hill, an M.Phil. from Oxford University, where she was a Marshall Scholar, and a B.A. from Stanford University.
